STML
Stemline Therapeutics, Inc.
STML
STML
Delisted
STML was delisted on the 9th of June, 2020.
94 hedge funds and large institutions have $194M invested in Stemline Therapeutics, Inc. in 2020 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 36 increasing their positions, 25 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
57% less capital invested
Capital invested by funds: $449M → $194M (-$255M)
79% less call options, than puts
Call options by funds: $80K | Put options by funds: $388K
Holders
94
Holding in Top 10
2
Calls
$80K
Puts
$388K
Top Buyers
| 1 | +$5.17M | |
| 2 | +$4.52M | |
| 3 | +$4.29M | |
| 4 |
Goldman Sachs
New York
|
+$2.67M |
| 5 |
ELI
Empire Life Investments
Toronto,
Ontario, Canada
|
+$1.79M |
Top Sellers
| 1 | -$10.9M | |
| 2 | -$10.3M | |
| 3 | -$8.77M | |
| 4 |
Axa
Paris,
France
|
-$6.2M |
| 5 |
AG
Artal Group
Luxembourg
|
-$3.83M |
